Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference

Rhea-AI Summary

Organon (NYSE: OGN) announced that CEO Kevin Ali and CFO Matthew Walsh will participate in a fireside chat at Morgan Stanley's 19th Annual Global Healthcare Virtual Conference on September 13, 2021, at 9:30 a.m. EDT. Investors and the public can access the live webcast at Organon Events. Organon focuses on women's health and has over 60 products, including reproductive health and biosimilars. The company aims to invest in growth opportunities and collaborate with biopharmaceutical innovators.

JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference on Monday, September 13, 2021 at 9:30 a.m. EDT.

Investors, analysts, members of the media and the general public are invited to watch a live video webcast of the presentation at https://www.organon.com/investor-relations/events-and-presentations/.

About Organon

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development like recently acquired Alydia Health, a medical device company focused on postpartum hemorrhage. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging Organon’s scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with its headquarters located in Jersey City, New Jersey.

For more information, visit http://www.organon.com and connect with us on LinkedIn and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005139/en/

Media:

Karissa Peer

(614) 314-8094

Kate Vossen

(732) 675-8448



Investor:

Jennifer Halchak

(201) 275-2711

Edward Barger

(267) 614-4669

Source: Organon & Co.

FAQ

When is Organon's participation in the Morgan Stanley Global Healthcare Virtual Conference?

Organon will participate in the conference on September 13, 2021, at 9:30 a.m. EDT.

Who will represent Organon at the Morgan Stanley conference?

CEO Kevin Ali and CFO Matthew Walsh will represent Organon at the conference.

Where can I watch the Organon conference presentation live?

You can watch the live video webcast at Organon's investor relations page: https://www.organon.com/investor-relations/events-and-presentations/.

What is Organon's primary focus as a company?

Organon primarily focuses on improving women's health throughout their lives.

What types of products does Organon offer?

Organon offers over 60 medicines and products across various therapeutic areas, mainly in women's health.